title: Onychomycosis in children: an overview.
abstract: Onychomycosis in children is relatively uncommon, with a prevalence of approximately 0.3% worldwide. The most common etiologic organism in Trichophyton rubrum. The oral antifungal agents terbinafine, itraconazole, and fluconazole, and the topical nail lacquers ciclopirox and amorolfine, are not approved for use in treating onychomycosis in children. However, these agents appear to be effective and safe in this indication.
authors.affiliation: Division of Dermatology, Department of Medicine, Sunnybrook and Women's College Health Sciences Center (Sunnybrook Site), University of Toronto, Toronto, Canada. agupta@execulink.com
authors.forename: Aditya K
authors.initials: AK
authors.lastname: Gupta
authors.forename: Alayne R
authors.initials: AR
authors.lastname: Skinner
authors.forename: Robert
authors.initials: R
authors.lastname: Baran
mesh_terms: D000935:Antifungal Agents / Q000008:administration & dosage*; D002648:Child; D006801:Humans; D014009:Onychomycosis / Q000188:drug therapy* / Q000503:physiopathology; D014249:Trichophyton / Q000145:classification / Q000187:drug effects
chemical_list: D000935:Antifungal Agents